There are no medical conditions or diseases under investigation.
Conditions
Interventions
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: - 18 years or older Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 60 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: - Serious reading problems (dyslexia) - Medical illness, indicating a risk in using haloperidol (e.g., cardiac illness, depression, thyroid disorders, glaucoma) - Current or recent use (<2 weeks before participation) of psycho-pharmacological medication (other than contraceptives), psychotropic drugs or drugs that might interfere with haloperidol. - Known drugs allergies - Pregnancy or lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: The main goal of the study is to investigate if small amounts of dopamine could influence engagement during reading, comprehension of the story and vocabulary learning and to investigate if the effect of dopamine is different for carriers of the long or short variant of the DRD4 gene. Additionally, the effect of dopamine on how participants value reading is investigated. ;Secondary Objective: Not applicable;Primary end point(s): - Task engagement: Index score for task engagement from EEG (beta/(alpha + theta)) - Story comprehension: Results for the comprehension questions - Vocabulary: Results for the vocabulary measure - Reading resistance: Presence or absence of attentional bias for reading related stimuli on the dot-probe task and/or the emotional Stroop task. ;Timepoint(s) of evaluation of this end point: Task engagement is measured during reading. Story comprehension, vocabulary and reading resistance are measured immediatley after reading the text. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): Not applicable;Timepoint(s) of evaluation of this end point: Not applicable | — |
Countries
Netherlands